Loading....
Loading....
Comprehensive health economics and policy consulting services partnering with key payers and decision makers to support reimbursement, healthcare reform, and policy frameworks.
Health economic studies delivered across MEA
Pharmacoeconomic models built & validated
Policy and market access projects completed
Countries served, with deepest presence in Egypt, KSA & UAE
We work directly alongside Ministries of Health, payers, and key decision-makers to build the evidence and engagement strategies that drive reimbursement success and sustainable market access.
Our studies cover payer landscape analysis, healthcare structure assessment, stakeholder mapping, and reimbursement pathway design - tailored to the regulatory and political realities of each MEA market
Our pharmacoeconomic models are built to meet the standards of local and international Health Technology Assessment (HTA) bodies.
We develop cost-effectiveness, cost-minimization, cost-benefit, and budget impact models that translate clinical data into economic arguments payers and policymakers can act on - with full transparency, local epidemiological calibration, and adaptation for MEA-specific payer requirements.
From national screening strategies to presidential health initiatives, we have a proven track record of shaping health policy at the highest levels of government across the MEA region.
Our work spans policy framework design, managed entry agreement (MEA) structuring, national initiative evaluation, and policy advocacy - grounded in rigorous health economics evidence and deep institutional relationships.
Strategic partnerships driving public health initiatives across the region
Accsight holds active working relationships with 20+ government bodies and health authorities across the MENA region.
Our government relationships enable faster payer engagement, smoother HTA submissions, and deeper policy insight for pharma partners
